InNexus Biotechnology, Inc.

InNexus Biotechnology, Inc.

  • 1400 400 Burrard Street Vancouver
  • Berkeley, California
  • 94710

Description

Business Strategy InNexus Biotechnology, Inc. is a publicly held British Columbia Corporation (IXS) formed in 2001 and publicly traded since 2003. InNexus is an innovative antibody-driven drug development company that has developed Dynamic Cross Linking™ Antibody Platform, formerly SuperAntibodies™ which improve the potency of existing antibody products and create a novel class of antibody based drugs.

Companies nearby